Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs when needed may help sustain persistence.

Studies in a new meta-analysis show sex differences in average weight loss, but similar benefits across other sub-groups.

Serena Williams is embracing her swimsuit body amid her GLP-1 weight loss journey. “I am not perfect…but I’m perfectly me,” Williams, 44, wrote via Instagram on Friday, March 13, alongside a photo of ...

Insurers said they had to withdraw coverage because the pricey medicines overwhelmed their budgets, forcing patients to either go off the drugs or pay for them out of pocket.

A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...

A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

Raleigh Weight Loss Center warns of GLP-1 medication risks & offers safe, natural weight loss solutions focusing on ...